Benjamin Israelow

6.7k total citations · 2 hit papers
15 papers, 1.5k citations indexed

About

Benjamin Israelow is a scholar working on Infectious Diseases, Hepatology and Molecular Biology. According to data from OpenAlex, Benjamin Israelow has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Benjamin Israelow's work include SARS-CoV-2 and COVID-19 Research (6 papers), Hepatitis C virus research (6 papers) and COVID-19 Clinical Research Studies (4 papers). Benjamin Israelow is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Hepatitis C virus research (6 papers) and COVID-19 Clinical Research Studies (4 papers). Benjamin Israelow collaborates with scholars based in United States and France. Benjamin Israelow's co-authors include Matthew J. Evans, Akiko Iwasaki, Tianyang Mao, Marion Sourisseau, Robert Homer, Brian D. Brown, Huiping Dong, Gavriel Mullokandov, Eric Song and Alessia Baccarini and has published in prestigious journals such as Science, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Benjamin Israelow

15 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses

2022 209 citations Tianyang Mao, Benjamin Israelow et al. Science profile →
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination

2023 107 citations Alexandra Suberi, Tianyang Mao et al. Science Translational Medicine profile →

Peers

Benjamin Israelow

MB

ID

EPIDE

CR

IMMUN

Xianfang Wu United States

Fengxiang Wang China

Haisheng Yu China

Viet Loan Dao Thi Germany

Nicole A. de Weerd Australia

Takeshi Sato Japan

Lingxiang Mao China

Christine Thumann France

Ahmad Yatim France

Stefania Varchetta Italy

Xianfang Wu United States

Benjamin Israelow

972 ×1.7

MB

390 ×0.7

ID

551 ×1.7

EPIDE

123 ×0.4

CR

672 ×2.3

IMMUN

Citations per year, relative to Benjamin Israelow Benjamin Israelow (= 1×) peers Xianfang Wu

Countries citing papers authored by Benjamin Israelow

Since Specialization

Citations

This map shows the geographic impact of Benjamin Israelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Israelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Israelow more than expected).

Fields of papers citing papers by Benjamin Israelow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Israelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Israelow. The network helps show where Benjamin Israelow may publish in the future.

Co-authorship network of co-authors of Benjamin Israelow

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Israelow. A scholar is included among the top collaborators of Benjamin Israelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Israelow. Benjamin Israelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Mao, Tianyang, et al.. (2025). Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice. Nature Immunology. 26(6). 908–919. 5 indexed citations

2.

Suberi, Alexandra, Tianyang Mao, Benjamin Israelow, et al.. (2023). Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination. Science Translational Medicine. 15(709). eabq0603–eabq0603. 107 indexed citations breakdown →

3.

Mao, Tianyang, Benjamin Israelow, Mario A. Peña-Hernández, et al.. (2022). Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science. 378(6622). eabo2523–eabo2523. 209 indexed citations breakdown →

4.

Sefik, Esen, Benjamin Israelow, Haris Mirza, et al.. (2021). A humanized mouse model of chronic COVID-19. Nature Biotechnology. 40(6). 906–920. 70 indexed citations

5.

Zhao, Min, Yingxia Hu, M. Katherine Cook, et al.. (2021). Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2. PLoS Pathogens. 17(6). e1009683–e1009683. 11 indexed citations

6.

Israelow, Benjamin, Tianyang Mao, Jon Klein, et al.. (2021). Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. Science Immunology. 6(64). eabl4509–eabl4509. 103 indexed citations

7.

Israelow, Benjamin, Eric Song, Tianyang Mao, et al.. (2020). Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. The Journal of Experimental Medicine. 217(12). 270 indexed citations

8.

Midkiff, Bentley R., Benjamin Israelow, Matthew J. Evans, et al.. (2017). Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R. mBio. 8(2). 27 indexed citations

9.

Hopcraft, Sharon E., Kristopher D. Azarm, Benjamin Israelow, et al.. (2015). Viral Determinants of miR-122-Independent Hepatitis C Virus Replication. mSphere. 1(1). 21 indexed citations

10.

Israelow, Benjamin, et al.. (2014). HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection. Hepatology. 60(4). 1170–1179. 54 indexed citations

11.

Israelow, Benjamin, Gavriel Mullokandov, Judith Agudo, et al.. (2014). Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors. Nature Communications. 5(1). 5408–5408. 57 indexed citations

12.

Sourisseau, Marion, et al.. (2013). Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies. PLoS Pathogens. 9(3). e1003244–e1003244. 59 indexed citations

13.

Mullokandov, Gavriel, Alessia Baccarini, Albert Ruzo, et al.. (2012). High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nature Methods. 9(8). 840–846. 315 indexed citations

14.

Israelow, Benjamin, et al.. (2011). HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle. Journal of Virology. 85(22). 12087–12092. 108 indexed citations

15.

Hopcraft, Sharon E., et al.. (2010). Species-Specific Regions of Occludin Required by Hepatitis C Virus for Cell Entry. Journal of Virology. 84(22). 11696–11708. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact